Heterogeneity of SSTR2 expression assessed by 68 Ga-DOTATOC PET/CT using coefficient of variation in patients with neuroendocrine tumors

High levels of somatostatin receptor type 2 (SSTR2) is a prerequisite for therapy with unlabeled or labeled somatostatin analogues. However, it is still unclear how the heterogeneity of SSTR2 expression could affect tumor response to therapy. The aim of our study was to test the ability of an imagin...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of Nuclear Medicine 2022-10, Vol.63 (10), p.1509-1514
Hauptverfasser:	Fonti, Rosa, Panico, Mariarosaria, Pellegrino, Sara, Pulcrano, Alessandro, Vastarella, Luisa Alessia, Hakkak, Armin, Giuliano, Mario, Palmieri, Giovannella, De Placido, Sabino, Del Vecchio, Silvana
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!